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Study of the metabolic and hormonal changes in exchange transfusions has clinical importance and biological interest. This essential therapeutic procedure is still associated with an appreciable mortality, the cause of which is not always clear (Weldon and Odell, 1968) . It is important to analyse further the profound metabolic and hormonal changes known to occur during exchange transfusion (see Anderson et al., 1963; Calladine et al., 1965; Milner and Wright, 1966; Schiff et al., 1971) are pertinent to the optimal management of infants with erythroblastosis and which may be of general biological relevance to the normal newborn infant.
The effect of glucose in blood preserved with acid citrate and glucose has been studied in 2 groups of term infants, one of normal birthweight and the other small-for-dates.
Patients and Methods
Two groups of infants of 37-40 weeks' gestational age were studied: 13 had a normal birthweight and 10 were small for their gestational age judged by the criteria of Butler and Alberman (1969) . Clinical details of the 2 groups of infants are presented in Table I The exchange transfusions were performed by umbilical vein catheterization through which blood was withdrawn and injected in 20 ml aliquots. The catheter was inserted the minimum distance for easy withdrawal of blood, usually 4-6 cm. The infant was transfused on an 'Infant Warmer' (Air-Shields) set so that the ambient temperature was between 30 and 35 -5 'C. The donor blood passed through a 700 cm plastic coil (Hem-o-gard Blood Warming Coil) immersed in water at 36-5-38-5 'C en route to the infant. The right midaxillary skin temperature was recorded continuously with a temperature monitor (Air-Shields) and was between 34 0 and 37 4 'C at the start of the transfusion. No significant change was noted in the mean ambient temperature and the mean temperature of the water in the different groups of infants studied. The mean skin temperatures of the different groups of infants were not significantly different at the start of the transfusion and did not alter significantly during the transfusion. Transfusions were performed at a wide range ofpostnatal ages, but there was little difference in the mean postnatal age at transfusion between groups. The mean rate of transfusion and the mean time of the transfusion after the last feed were similar in the different groups. The blood volume of the infant was calculated as 85 ml/kg body weight and the volume of blood exchanged was expressed as a fraction of the blood volume of the infant (Table I ). The volume exchanged was similar in the 2 NFD and the 2 SFD groups.
Blood specimens were collected in heparinized tubes from the donor bottle at the start of the exchange, from the infant before the injection of donor blood, and after the injection of 100, 200, 300, and 400 ml.
Waste blood was collected in a heparinized measuring cylinder. At the end of the transfusion the volume of waste blood was measured and a specimen was collected for analysis. The haematocrit of all blood specimens was measured immediately and the plasma was then separated by centrifugation within 10 minutes. Aliquots of plasma were stored at -20 CC for hormone analysis.
Plasma metabolite concentrations were measured within 24 hours on specimens stored at +4 'C. Plasma specimens for hormone analysis were thawed once only.
Plasma glucose was measured using glucose oxidase (Trinder, 1969) , plasma FFA by the method of Duncombe (1964) , and plasma glycerol by the method of Eggstein and Kreutz (1966) Acid citrate blood Glucose (mg/100 ml) 89±3 (7) 83±5 (7) 83±4 (7) 85±4 (7) 82±5 (7) 79+5 (4) FFA (,umol/l.) 268+38 (7) 883±160 (7) 805 ±153 (7) 743±135 (7) 723±127 (7) 631±248 (4) Glycerol (tLmol/l.) 55±11 (7) 88±12 (7) 88±17 (7) 69±11 (7) 83±21 (7) 79±32 (4) Insulin (,uU/ml) 24±4 (7) 26±4 (7) 29±3 (7) 26±4 (7) 25±2 (7) 19±1 (4) (3) GH (ng/ml) 3-0±0*8 (7) 33±12 (7) 28±9 (7) 25 ±5 (7) 24±6 (7) 27±8 (4) Acid citrate dextrose blood Glucose (mg/100 ml) 386±35 (10)* 75±4 (10) 120±3 (10)* 139±4 (10)* 153±8 (10)* 157±14 (8)* FFA (Vmol/l.)
302±47 (10) 1299±155 (10) 983±80 (10) 817±72 (10) 596±70 (10) 503±70 (8) Glycerol (,umol/l.) 63±11 (10) 114±23 (10 The total amount of a substance in the plasma of the donor blood given to the infant was estimated from the expression: T = V C (100 -H)/100, where T was the total amount of the substance infused, V was the total blood volume infused, C was the plasma concentration of the substance, and H was the haematocrit. The total amount of a substance removed from the infant was calculated similarly, paying careful attention to the volume, haematocrit, and plasma concentration of the substance in the waste blood and each of the blood samples taken from the infant for analysis. If more of a hormone or metabolite was infused than was removed, the infant was described as being in positive balance and vice versa.
Results Two types of exchange transfusion (ACD and AC) were performed on 2 clinical groups of infants (NFD and SFD). Since similar results were obtained with ACD and AC transfusions in each clinical group, the results for the NFD groups only are described in detail (Tables II and in  part of Table IV , Fig. 1 and 2) Acid citrate blood Glucose (mg/100 ml) 92±6 (7) 78 ±5 (7) 82±5 (7) 84 ±5 (7) 82 ±5 (7) 89±6 (4) FFA (itrmol/l.)
354±53 (7) 897±113 (7) 784±73 (7) 756±82 (7) 725 ±82 (7) 594±119 (4) Glycerol (,umol/l.) 39±11 (7) 60±12 (7) 54±16 (7) 64±23 (7) 58±27 (7) 39±11 (4) Insulin (,uU/ml) 31±6 (7) 23±4 (7) 25±6 (7) 22±2 (7) 22±4 (7) 24±4 (4 (4) Glycerol (gmol/l.)
53420 (5) 123±37 (5) 83±13 (5) 73±9 (5) 80±20 (5) 84±14 (4) Insulin (,uU/ml) 32±2 (6) 27±5 (6) 58±5 (6) (10) 0-59±0-17t
5-62±1-43 (7) Figures in parentheses indicate the number of pairs of observations.
The amount infused differs statisticaUy from the amount removed: *P <0-001, tP <0.005, tP <0 05.
group.bmj.com on June 15, 2017 -Published by http://adc.bmj.com/ Downloaded from mean plasma GH concentration of the infant in the ACD transfusions which was significant from 100 ml onwards. In the AC transfusions the plasma GH level of the infant remained steady. In both ACD and AC transfusions there was a large negative balance of GH. The mean negative balance of GH in ACD transfusions was 13 6 ± 2 3 ,ug which was significantly greater than that in AC transfusions: 5 *0 ± 1 4 ,ug (P < * 02).
Free fatty acids. In ACD and AC transfusions there was a similar mean negative balance in FFA. The mean difference between the plasma FFA of the infant and that of the donor blood at the start of ACD transfusions was 986 ± 127 ,umol/l., which was not significantly greater than that in AC transfusions, 643 ± 166 ,umol/l. During the ACD and AC transfusions the mean fall in plasma FFA between the first and last samples from the infant was 745 ± 138 ,tmol/l. and 170 i 63 ,umol/ 1., respectively. The fall in plasma FFA concentration in ACD transfusions was significantly greater than that in AC transfusions (P <0 01).
Glycerol. The mean plasma glycerol level in the infants receiving either type of transfusion was slightly but not significantly higher than that in the donor blood. During the transfusions no significant change in plasma glycerol occurred. In both groups there was a similar negative glycerol balance.
Glucagon. In both types of transfusion there was a similar negative glucagon balance, which was significant, however, only in the ACD transfusions. In both groups the mean donor plasma glucagon level was less than that in the infant at the start of the transfusion, but, again, the difference was significant only in the ACD group (P <0 02). During the transfusion there was a gradual fall in the mean plasma glucagon in both groups and in the last sample from infants having ACD transfusions the plasma glucagon was significantly lower than at the start of the transfusion (P <0 02).
Small-for-dates group. The results from the AC and ACD transfusions in the SFD group are presented in Table III . In all respects the results from the SFD and NFD groups were qualitatively and quantitatively similar. In some cases changes in plasma concentrations or balances of metabolites or hormones were not significant in the SFD group when significant differences were found in the NFD group. This was due mainly to the group sizes.
Discussion
This study of the effect of glucose on the metabolic and hormonal changes in exchange transfusion was prompted by the desire to investigate the effect of glucose on glucagon secretion in the human newborn and to reinvestigate the effect of glucose infusion on GH secretion. Milner and Wright (1966) observed that plasma GH levels did not fall during exchange transfusions despite the fact that the plasma concentration of GH in the infant was more than 10 times that in the donor blood. They inferred that increased GH secretion occurred to make good the GH lost in the transfusion and that glucose was the stimulus to GH secretion. Others (Cornblath et al., 1965; Westphal, 1968; Wolf, Stubbe, and gabata, 1970 ) also found that hyperglycaemia in the newborn was associated with a rise in plasma GH levels, and deduced that the relation was causal. More recently emphasis has been placed on the fact that stress is a potent stimulus of GH release in older children (Helge, Weber, and Quabbe, 1969) (7) 45-8±8-7t 169-8±27-5 (5) 61-8±10-7* 153-2±12-5 (7) 9-0±3-5t
19-8±4-1 (6) 6-5±1-7
12-2±3-2 (7) 5-23±0-85t
12-30±2-23 (6) 5-08±0-93 4-20±0-55 (7) 53-6±13-6 102-4±14-3 (5) 0-38±0-07t 13-2±2-9 (5) 0-59±0-13t
8-84±1-48 (7) group.bmj.com on June 15, 2017 -Published by http://adc.bmj.com/ Downloaded from this idea is the observation that repeated heel pricks in the newborn do not cause a rise in plasma GH levels (Milner and Wright, 1967; Stubbe and Wolf, 1971) . Since two similar groups have been studied, valid comparisons can be made between them regarding the cause and effect of insulin secretion in erythroblastosis fetalis. The glucose in ACD transfusions caused a rise in plasma glucose and insulin similar to that reported previously (Milner and Wright, 1966) . No significant change occurred in the plasma levels or balances of glucose and insulin in AC transfusions. These observations, when coupled with the finding that in ACD transfusions there was a significant negative balance of insulin and a significant positive balance of glucose, demonstrate that insulin secretion occurred in response to the glucose infusion. It is not known whether insulin stimulated the cellular uptake of glucose, as the volume of distribution of glucose is greater than the plasma space. The rise in plasma glucose during the transfusion did not necessarily indicate the distribution of glucose in other compartments.
In both types of exchange transfusion there was a similar negative FFA and glycerol balance. Glucose infusion had no effect on plasma glycerol levels which remained steady during the transfusion and the negative glycerol balance in each type of transfusion can be explained by the lower plasma glycerol levels in donor blood. Thus, as for GH, there was a net production of glycerol in both AC and ACD transfusions. For FFA, there was an important difference between ACD and AC transfusions. Despite the similar difference between the plasma FFA levels in the donor blood and the infant at the start of the transfusion, in ACD transfusions there was a significantly greater fall in plasma FFA than in infants receiving AC transfusions. It may be concluded that in ACD transfusions FFA disappeared from the infant's intravascular compartment in addition to being washed out of the infant. The inference is that net lipogenesis was stimulated by hyperglycaemia and secondary hyperinsulinaemia.
There is little information on glucagon secretion in the human newborn. Milner, Fekete, and Assan (1972) have shown that infants with erythroblastosis have higher plasma glucagon levels than normal infants. The levels were also higher than those in the donor blood, which was representative of adult peripheral venous blood collected postprandially. In the normal adult glucose infusion causes a fall in plasma glucagon levels (Unger et al., 1970) , and it was of interest to see if this occurred in the newborn. In both ACD and AC transfusions there was a similar negative balance and a similar gradual fall in plasma glucagon levels during the transfusion. The findings could be explained by the difference in the plasma glucagon in the blood of the donor and infant at the start of the transfusion. The differences between ACD and AC transfusions were due to the fact that the mean difference between the donor and infant plasma glucagon was greater in the ACD than in the AC transfusions. It is possible to conclude that glucose infusion had no effect on glucagon secretion in the transfusions. However, it must be noted that the conditions of collection of blood samples for glucagon assay were not ideal (Heding, 1971) . The possibility exists that glucagon was partially destroyed during collection and that larger changes in plasma levels and glucagon balance could have occurred during the transfusion than those actually recorded.
The concept of 'small-for-dates' is of doubtful validity when applied to infants with erythroblastosis fetalis. However, since differences in insulin secretion have been shown between normally grown and small-for-dates infants who are otherwise normal (Le Dune, 1972) , it seemed preferable to subdivide the infants in the present study into 2 clinically defined subgroups. The fact that similar results were obtained in both NFD and SFD infants emphasizes the qualitative and quantitative validity of the results.
